T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Olema Pharmaceuticals
OLMA
$920M
| $298K | ﹤0.01% |
26,251
+1,486
| +6% | +$19.2K |
|
2427
Superior Group of Companies
SGC
$210M
| $298K | ﹤0.01% |
18,003
-5,497
| -23% | -$79.2K |
|
2428
Digital Turbine
APPS
$1.53B
| $296K | ﹤0.01% |
112,797
+41,261
| +58% | +$175K |
|
2429
Mastech Digital
MHH
$95.3M
| $296K | ﹤0.01% |
32,884
| – | – |
|
2430
PDF Solutions
PDFS
$2.13B
| $296K | ﹤0.01% |
8,784
+1,317
| +18% | +$43.2K |
|
2431
Winmark
WINA
$1.26B
| $296K | ﹤0.01% |
816
+103
| +14% | +$37.8K |
|
2432
Bowman Consulting
BWMN
$731M
| $294K | ﹤0.01% |
8,425
+393
| +5% | +$13.5K |
|
|
LAZR
2433
DELISTED
Luminar Technologies
LAZR
| $294K | ﹤0.01% |
9,935
+2,304
| +30% | +$84K |
|
|
PLYM
2434
DELISTED
Plymouth Industrial REIT
PLYM
| $293K | ﹤0.01% |
13,008
+1,892
| +17% | +$42.2K |
|
|
SP
2435
DELISTED
SP Plus Corporation
SP
| $293K | ﹤0.01% |
5,598
+650
| +13% | +$33.5K |
|
2436
Mativ Holdings
MATV
$667M
| $292K | ﹤0.01% |
15,556
+2,273
| +17% | +$33.9K |
|
2437
MediaAlpha
MAX
$813M
| $292K | ﹤0.01% |
14,321
+1,235
| +9% | +$19.7K |
|
2438
FuboTV Inc
FUBO
$296M
| $291K | ﹤0.01% |
15,318
+769
| +5% | +$20.1K |
|
2439
ANI Pharmaceuticals
ANIP
$1.72B
| $289K | ﹤0.01% |
+4,169
| New | +$252K |
|
2440
Monarch Casino & Resort
MCRI
$2.2B
| $289K | ﹤0.01% |
3,851
+443
| +13% | +$30.7K |
|
2441
Pixelworks
PXLW
$45.7M
| $288K | ﹤0.01% |
9,292
| – | – |
|
2442
QCR Holdings
QCRH
$1.75B
| $287K | ﹤0.01% |
4,713
+539
| +13% | +$30.9K |
|
2443
Argan
AGX
$7.84B
| $286K | ﹤0.01% |
5,656
+539
| +11% | +$25.3K |
|
2444
IES Holdings
IESC
$14.9B
| $286K | ﹤0.01% |
+2,347
| New | +$225K |
|
2445
ReposiTrak
TRAK
$158M
| $286K | ﹤0.01% |
18,000
| – | – |
|
2446
Energy Fuels
UUUU
$3.64B
| $285K | ﹤0.01% |
45,164
+5,889
| +15% | +$39.7K |
|
2447
Clean Energy Fuels
CLNE
$395M
| $284K | ﹤0.01% |
105,763
+26,356
| +33% | +$78.6K |
|
2448
Carriage Services
CSV
$555M
| $284K | ﹤0.01% |
10,475
+746
| +8% | +$18.7K |
|
2449
Usana Health Sciences
USNA
$252M
| $284K | ﹤0.01% |
5,849
+494
| +9% | +$24.2K |
|
2450
Alkami Technology
ALKT
$2.22B
| $283K | ﹤0.01% |
11,502
+1,460
| +15% | +$35.8K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.